ARCHIVES

Advisors’ Report On Intramural Program To Recommend Restructuring

This article is from The Cancer Letter archive.

Vol. 21 No. 15 | April 14, 1995

Download PDF Visit The Full Archive

Related Articles

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

June 28, 2013

Season’s Greetings from the Cancer Letter

December 17, 1999

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Fisher, Bonadonna Studies Still Fuel DeVita’s Optimism; Carbon Lists Six Basic Research Needs

July 15, 1977

Science Policy: Stem Cell Research Guidelines Formalize NIH Funding Polices

December 3, 1999

Okunieff To Lead SWOG Radiation Committee

July 19, 2002